CIPO Patents = 12

EPO Patents = 2

Forward Citations = 1

Loading Chart...

12 inventors (with patents filed for the assignee):

Kazuhiro Matsuda (4 out of 7 patents)

Yuko Sasaki (2 out of 36 patents)

Yuko Shingu (2 out of 2 patents)

4. Koji Ichiyama (2 out of 2 patents)

5. Sachie Matsuda (2 out of 2 patents)

6. Ryo Harasawa (2 out of 2 patents)

7. Yoshihiro Nishida (2 out of 2 patents)

8. Norio Katayama (2 out of 2 patents)

9. Yasuo Endo (2 out of 2 patents)

10. Nobuo Nomura (2 out of 2 patents)

11. Yoshichika Arakawa (2 out of 3 patents)

4 patents: Sort by Forward Citations

1. 10870669 - Method for producing an isolated monoclonal antibody specifically binding to a glycolipid antigen of (2020-12-22),

2. 10232026 - Vaccine for mycoplasma infection (2019-03-19),

3. 9539209 - Vaccine for mycoplasma infection (2017-01-10),

4. 8367076 - [object Object] (2013-02-05),

M Bio Technology Inc. is a leading biotechnology company that specializes in developing innovative solutions for the healthcare industry. With a focus on research and development, the company aims to create cutting-edge products and technologies that improve patient outcomes and enhance quality of life. M Bio Technology Inc. is dedicated to advancing the field of biotechnology through their commitment to excellence and scientific innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#2,786 in Tokyo

#7,416 in Japan

Tokyo, Japan

M Bio Technology Inc.

Forward Citations = 1

12 inventors:

Kazuhiro Matsuda (4 out of 7 patents)

Yuko Sasaki (2 out of 36 patents)

Yuko Shingu (2 out of 2 patents)

4. Koji Ichiyama (2 out of 2 patents)

5. Sachie Matsuda (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

12 patents (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com